Abstract

Macrophage activation syndrome (MAS) – is a severe life-threatening hematological condition, mostly complicated systemic juvenile idiopathic arthritis (SJIA). Early detection of MAS can lead to appropriate therapeutic interventions and change the outcomes. There are no strict criteria for early MAS detection in SJIA. Currently applied HLH criteria can determinate only advanced stage of MAS, which lead to delay diagnosis, late start of specific treatment and associated with poor outcomes. There are several sets of preliminary criteria of MAS in SJIA.

Highlights

  • Macrophage activation syndrome (MAS) – is a severe lifethreatening hematological condition, mostly complicated systemic juvenile idiopathic arthritis (SJIA)

  • Our retrospective study was based on reviewing the medical charts of the children, admitted to the rheumatology department with active SJIA and definite MAS (n=18) and without MAS (n=40)

  • We evaluated the data related to SJIA and MAS at the moment of the patient’s admission

Read more

Summary

Introduction

Macrophage activation syndrome (MAS) – is a severe lifethreatening hematological condition, mostly complicated systemic juvenile idiopathic arthritis (SJIA). Detection of MAS can lead to appropriate therapeutic interventions and change the outcomes. There are no strict criteria for early MAS detection in SJIA. Applied HLH criteria can determinate only advanced stage of MAS, which lead to delay diagnosis, late start of specific treatment and associated with poor outcomes. There are several sets of preliminary criteria of MAS in SJIA

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call